Increased Antitumor Activity of Bevacizumab in Combination With Hypoxia Inducible Factor-1 Inhibition
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-09-0274
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2009
Authors
Publisher
American Association for Cancer Research (AACR)